Cargando…
Corrigendum to Clinicopathological analysis of early-stage breast cancer patients that meet indications for BRCA1/2 genetic testing
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369174/ https://www.ncbi.nlm.nih.gov/pubmed/32694906 http://dx.doi.org/10.21147/j.issn.1000-9604.2020.03.13 |
Ejemplares similares
-
Clinicopathological analysis of early-stage breast cancer patients that meet indications for BRCA1/2 genetic testing
por: Xiang, Hongyu, et al.
Publicado: (2020) -
Clinical analysis of 21-gene relapse score test in hormone receptor-positive early-stage breast cancer
por: Zhu, Lizhe, et al.
Publicado: (2021) -
Clinicopathological and Gene Mutation Analysis of 27 Cases with Extranodal Rosai–Dorfman Disease [Corrigendum]
Publicado: (2022) -
Corrigendum to “Mucinous Histology, BRCA1/2 Mutations, and Elevated Tumor Mutational Burden in Colorectal Cancer”
por: Harpaz, Noa, et al.
Publicado: (2020) -
Corrigendum to Clinicopathologic Analysis of Oral Squamous Cell Carcinoma After 125I Interstitial Brachytherapy
Publicado: (2020)